A Different Kind of Nine Months: Lymphoma While Pregnant

"Share Your Story" Spotlight, By: Michele Owen

When I was 39 I became pregnant with my second child. Straight away I felt ill but attributed it to being 10 years older during this pregnancy than my last. As the weeks went on I felt worse and worse. I was exhausted all the time, I couldn't breathe, and I was getting a weird numb feeling in my right arm. My breathing was thought to be asthma, and I was told the numb feeling was a trapped nerve. I was also losing a lot of weight. Things just got worse until one night, when I was about 23 weeks pregnant, I phoned Accident & Emergency because I could not breathe and I thought I was having a heart attack.

I was admitted into hospital where they completed many tests but could not figure out what was wrong with me. They did tell me, however, that there was a large shadow on my left lung! After two weeks in the hospital and two biopsies later, they decided to move me to the University Hospital of Wales. There I had yet another biopsy before they told me that I had a large, 12-centimeter mass in my chest and that it was Hodgkin's lymphoma.

After meeting with my fantastic consultant I was told that I had the choice - either deliver at 26 weeks or start my chemotherapy while pregnant, but either way I needed chemo straight away! After a lot of soul searching and a lot of talks with my doctor, I decided to go ahead with the chemo until I reached 32 weeks, and then they would deliver the baby. I had two cycles of chemo over the next few weeks, and I had scans twice weekly to make sure that the baby was still growing. She was a little fighter!

Katie was delivered on July 29 by C-section at 32 weeks. She weighed four pounds and four ounces. I got the quickest look at her before she was whisked away to SCBU (Special Care Baby Unit). The next day was my 40th birthday, and I got the best present I could ever ask for - being able to hold my newborn Katie. I started the next round of chemo the following week, about five days after my C-section.

Katie and I left the hospital together when she was just eight days old. She was such a fighter! I won't pretend it wasn't hard because it was incredibly difficult, but I went on to have the rest of my chemo, then radiotherapy, and now I'm seven years clear! Katie is a happy, healthy child with no obvious side effects of everything she went through, so for me this was definitely the right decision.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap